Mental health outcomes following a psilocybin session within Oregon’s state-regulated model: A naturalistic study
medRxiv February 19, 2026 Amanda Gow, Emily Shih, Ryan Reid et al. preprint
Abstract Background In 2020, Oregon became the first U.S. state to establish a regulated framework for adults to access psilocybin services using naturally-derived mushroom products. No studies have examined mental health outcomes among individuals receiving psilocybin in this context. Aims To evaluate changes in self-reported symptoms of depression, anxiety, and well-being 30-days...
DOI: 10.64898/2026.02.18.26346580 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Major depressive disorder
Mental health
Naturalistic observation
+6